glp-1 weight loss research The revolution: What UAB researchers are discovering about how these drugs work Discovery of GLP-1–Based Drugs for

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Liraglutide improved cardiometabolic parameters more in obese than in non-obese patients with type 2 diabetes: a real-world 18-month prospective study

Recent pharmacovigilance research has identified elevated reporting odds ratios for hair loss with semaglutide (2.46) and tirzepatide (1.73), suggesting a real association between these medications and increased shedding

Miles today

Conner Mertens 04:21 And just to mention that it was disproportionately affecting, you know, ethnic and racial minorities and folks from low income communities

We actually have clinical data on this